{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:49:17Z","timestamp":1786718957830,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Res Pharma Sci"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/1735-5362.283817","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T02:00:51Z","timestamp":1588644051000},"page":"174","source":"Crossref","is-referenced-by-count":0,"title":["The effects of two types of renin-angiotensin system inhibitors on the hypertension induced by new pressor protein associated with beta-factor XIIa in rats"],"prefix":"10.4103","volume":"15","author":[{"given":"Rahim","family":"Golmohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbar","family":"Pejhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Gohari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MohammadHassan","family":"Rakhshani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PeterC","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MuhammadIbrar","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1735-5362.283817-1","first-page":"217","volume-title":"Global burden of hypertension: analysis of worldwide data.Lancet?","author":"Kearney","year":"2005","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-2","first-page":"2287","volume-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematicanalysis for the global burden of disease study 2013.Lancet?","author":"GBD","year":"2015","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-3","first-page":"117","volume-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013.Lancet?","author":"GBD","year":"2015","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-4","first-page":"581","volume-title":"Activated plasma coagulation p-Factor XII-induced vasoconstriction in rats.Clin Sci (Lond)?","author":"Papageorgiou","year":"2012","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-5","first-page":"H837","volume-title":"Are cardiovascular and sympathoadrenal effects of human \u2018new pressor protein\u2019 preparations attributable to human coagulation p-FXIIa.Am J Physiol Heart Circ Physiol??","author":"Papageorgiou","year":"2004","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-6","first-page":"1523","volume-title":"Coagulation factor XIIa-kinin-mediated contribution to hypertension of chronic kidney disease.J Hypertens?","author":"Papageorgiou","year":"2014","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-7","first-page":"1025","volume-title":"Possible role of \u2018new pressor protein\u2019 in hypertensive anephric hemodialysis patients.Pediatr Nephrol?","author":"Pearl","year":"2003","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-8","first-page":"274","volume-title":"Formulation and in vitro evaluation of a fast-disintegrating\/sustained dual release bucoadhesive bilayer tablet of captopril for treatment of hypertension crises.Res Pharm Sci?","author":"Abbasi","year":"2016","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-9","first-page":"125","volume-title":"Hydroalcoholic extract of Allium eriophyllum leaves attenuates cardiac impairment in rats with simultaneous type 2 diabetes and renal hypertension.Res Pharm Sci","author":"Janahmadi","year":"2015","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-10","first-page":"566","volume-title":"Blood pressure lowering and safety improvements with liver angiotensinogen inhibitionin models of hypertension and kidney injury.Hypertension?","author":"Mullick","year":"2017","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-11","first-page":"1","volume-title":"Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.Cochrane Database Syst Rev?","author":"Li","year":"2014","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-12","first-page":"1474","volume-title":"Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use.J Am Coll Cardiol??","author":"Messerli","year":"2018","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-13","first-page":"22","volume-title":"The effects of human \u2018new pressor protein\u2019 and coagulation factor XIIa on blood pressure and heart rate in bilaterally nephrectomized rats.Iran J Med Sci","author":"Pejhan","year":"2007","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-14","first-page":"641","volume-title":"Role of the renin-angiotensin system in kidney development and programming of adult blood pressure.Clin Sci (Lond)?","author":"Almeida","year":"2020","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-15","first-page":"460","volume-title":"Stimulation of renin secretion by catecholamines is dependent on adenylyl cyclases 5 and 6.Hypertension?","author":"Aldehni","year":"2011","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-16","first-page":"e100","volume-title":"Angiotensin converting enzyme- regulated, noncholinergic sympathoadrenal catecholamine releasemediates the cardiovascular actions of human \u2018new pressor protein\u2019 related to coagulation beta-factor XIIa.Can J Cardiol?","author":"Papageorgiou","year":"2009","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-17","first-page":"1093","volume-title":"Human coagulation factor XII-related \u2018new pressor protein\u2019: role of PACAP in its cardiovascularand sympathoadrenal effects.Can J Cardiol","author":"Simos","year":"2002","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-18","first-page":"1173","volume-title":"Role of bradykinin B2- receptor in the sympathoadrenal effects of \u2018new pressor protein\u2019 related to human blood coagulation factor XII fragment.J Hypertens?","author":"Amfilochiadis","year":"2004","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-19","first-page":"21","volume-title":"Role of bradykinin in the actions of \u2018new pressor protein\u2019 related to human plasma pFXIIa.Koomesh","author":"Pejhan","year":"2004","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-20","first-page":"1","volume-title":"Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study.BMJ?","author":"Hicks","year":"2018","journal-title":""},{"key":"key-10.4103\/1735-5362.283817-21","first-page":"k4471","volume-title":"ACE inhibitors are linked to increased lung cancer risk, study finds.BMJ?","author":"Kmietowicz","year":"2018","journal-title":""}],"container-title":["Research in Pharmaceutical Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:41:56Z","timestamp":1786714916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1735-5362.283817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["283817"],"URL":"https:\/\/doi.org\/10.4103\/1735-5362.283817","relation":{},"ISSN":["1735-5362"],"issn-type":[{"value":"1735-5362","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}